Literature DB >> 17022924

Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation.

John A Astin1, Colleen Reilly, Cheryl Perkins, Wendy L Child.   

Abstract

The purpose of this study was to examine patterns and predictors of complementary and alternative medicine (CAM) among breast cancer patients. A review of the existing survey literature on CAM use for breast cancer was conducted with a series of eight focus groups (N = 67) to further examine the perspectives of breast cancer patients on CAM. The rates of CAM use varied from 17 to 75%, with a mean of 45%. Vitamins and minerals and herbs were the most frequently cited categories. Users tended to be younger, more educated, and more likely to have used CAM prior to their diagnosis. Focus group data indicate that breast cancer patients use a wide array of CAM for a variety of reasons, including symptom management, improving quality of life, and enhancing immune function. Although women rely on a variety of resources for information, they frequently experience frustration owing to the absence or conflicting nature of such information. Communication with conventional providers about CAM is frequently experienced as either unsupportive or not helpful by many patients. The results point to the value of developing better evidence-based informational resources related to CAM and cancer and the need for physicians to become better educated about CAM and how to communicate more effectively with their breast cancer patients about it.

Entities:  

Mesh:

Year:  2006        PMID: 17022924     DOI: 10.2310/7200.2006.019

Source DB:  PubMed          Journal:  J Soc Integr Oncol        ISSN: 1715-894X


  27 in total

1.  Complementary and alternative medicine use among cancer survivors: a population-based study.

Authors:  Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam
Journal:  J Cancer Surviv       Date:  2010-10-06       Impact factor: 4.442

Review 2.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

Review 3.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

Review 4.  Adverse events associated with complementary and alternative medicine use in ovarian cancer patients.

Authors:  Erin S Sweet; Leanna J Standish; Barbara A Goff; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2013-04-26       Impact factor: 3.279

5.  Canadian integrative oncology research priorities: results of a consensus-building process.

Authors:  L C Weeks; D Seely; L G Balneaves; H S Boon; A Leis; D Oneschuk; S M Sagar; M J Verhoef
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

6.  Yoga for Patients with Early Breast Cancer and its Impact on Quality of Life - a Randomized Controlled Trial.

Authors:  F Siedentopf; I Utz-Billing; S Gairing; W Schoenegg; H Kentenich; I Kollak
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-04       Impact factor: 2.915

7.  Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.

Authors:  M Robyn Andersen; Erin Sweet; Kimberly A Lowe; Leanna J Standish; Charles W Drescher; Barbara A Goff
Journal:  J Altern Complement Med       Date:  2013-02-27       Impact factor: 2.579

8.  Complementary and alternative medicine use among patients with thyroid cancer.

Authors:  Jennifer E Rosen; Paula Gardiner; Robert B Saper; Amanda C Filippelli; Laura F White; Elizabeth N Pearce; Rebecca L Gupta-Lawrence; Stephanie L Lee
Journal:  Thyroid       Date:  2013-07-25       Impact factor: 6.568

9.  Medical pluralism among American women: results of a national survey.

Authors:  Christine Wade; Maria Chao; Fredi Kronenberg; Linda Cushman; Debra Kalmuss
Journal:  J Womens Health (Larchmt)       Date:  2008-06       Impact factor: 2.681

10.  A systematic review of integrative oncology programs.

Authors:  D M Seely; L C Weeks; S Young
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.